![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 8, 6118-6123, February 22, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Molecular Oncology, Genentech, Inc., South
San Francisco, California 94080
Mutational activation of the Wnt signaling
pathway is a common early event in colorectal tumorigenesis, and the
identification of target genes regulated by this pathway will provide a
better understanding of tumor progression. Gene expression profiling on
oligonucleotide microarrays revealed reduced expression of the
immediate early genes fos and fosB following
stimulation of cells by Wnt-1. Further analysis demonstrated that serum
or 12-O-tetradecanoylphorbol-13-acetate activation
of several immediate early genes including fos,
fosB, junB, and egr1 was inhibited
by Wnt signaling. Wnt signaling inhibited transcriptional activation
driven by the serum response element without altering the activation of
the extracellular signal-regulated kinase cascade or ternary complex
formation at the fos serum response element promoter. The
Wnt-mediated repression of c-Fos, FosB, and JunB expression was
consistent with a decrease in their binding to an AP-1 promoter element
and decreased target gene transcription. The expression of
fos, fosB, junB, and
egr1 was also repressed in human colon tumors relative to
patient matched normal tissue. By contrast, the fos family
member fra-1 was up-regulated in the human colon tumors,
suggesting a compensatory mechanism for the reduction in
fos and fosB expression. The results indicate
that Wnt signaling can repress the expression of certain immediate early genes, and that this effect is consistent with changes in gene
expression observed in human colorectal tumors.
To whom correspondence should be addressed: Genentech, Inc. 1 DNA
Way, MS 40, South San Francisco, CA 94080. Tel.: 650-225-5327; Fax:
650-225-6443; E-mail: ppolakis@gene.com.
This article has been cited by other articles:
![]() |
K.-S. Park, S. H. Jeon, S.-E. Kim, Y.-Y. Bahk, S. L. Holmen, B. O. Williams, K.-C. Chung, Y.-J. Surh, and K.-Y. Choi APC inhibits ERK pathway activation and cellular proliferation induced by RAS J. Cell Sci., March 1, 2006; 119(5): 819 - 827. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Terra, I. Louis, R. Le Blanc, S. Ouellet, J. C. Zuniga-Pflucker, and C. Perreault T-cell generation by lymph node resident progenitor cells Blood, July 1, 2005; 106(1): 193 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Baumruker, R. Csonga, E. Pursch, A. Pfeffer, N. Urtz, S. Sutton, E. Bofill-Cardona, M. Cooke, and E. Prieschl Activation of mast cells by incorporation of cholesterol into rafts Int. Immunol., October 1, 2003; 15(10): 1207 - 1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. DEBINSKI, D. GIBO, and A. MINTZ Epigenetics in High-Grade Astrocytomas: Opportunities for Prevention and Detection of Brain Tumors Ann. N.Y. Acad. Sci., March 1, 2003; 983(1): 232 - 242. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |